跳至主要内容
临床试验/CTRI/2020/10/028491
CTRI/2020/10/028491尚未招募2 期

PhaseII non randomized clinical study on sooli kanam (Bronchial asthma) with evaluation of siddha trial drug - Kannaiku atthi nei

Government siddha medical college chennai1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年10月25日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
clinical assesment of bronchial asthma is carried out on the basis of modified asthma scale, and comparing the clinical symptoms before and after treatment

研究概览

简要总结

This is an phase II open single non randomized study to evaluate the official Siddha formulaiton "Kannaiku atthi nei" internally for Bronchial asthma (sooli kanam) . The trial drug is given 2 to 5 ml twice a day for 21 days. clinical trial conducted after conducting pre-clinical toxicity study. The trial drug Kannaiku atthi nei is mentioned in kumbamuni balavagadam book. During the trial study related data will be recorded and documented. after the completion of the trial all the data will be analysed statistically.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • age 3 to 12 years cough without expulsion wheezing dyspnea rhinitis.

排除标准

  • primary complex hypersensitivity pneumonitis lung abscess cystic fibrosis bronchiolitis.

结局指标

主要结局

clinical assesment of bronchial asthma is carried out on the basis of modified asthma scale, and comparing the clinical symptoms before and after treatment

时间窗: 21 days

次要结局

  • it is assessed by comparing the safety parameters before and after treatment(21 days)

研究者

发起方
Government siddha medical college chennai
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

clinical study on sooli kanam (Bronchial asthma)... | 临床试验